Ongoing measles transmission across multiple U.S. outbreaks continues to drive case counts sharply higher, with the CDC confirming 2,777 cases through August 20, 2026—already exceeding the full-year 2025 total of 2,289. Roughly 94% of 2026 infections link to 36 active outbreaks, concentrated in communities with lower MMR vaccination coverage that enable sustained chains of the highly contagious virus. Weekly CDC surveillance updates have added 100–211 cases recently, reflecting both local spread and travel-related introductions. With the August 31 resolution date approaching, the next CDC report expected late this week will provide the final confirmed tally before market close, highlighting how vaccination gaps and outbreak persistence shape the trajectory of this year’s record resurgence.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · AggiornatoCasi di morbillo negli Stati Uniti entro il 31 agosto?
Casi di morbillo negli Stati Uniti entro il 31 agosto?
NUOVO
31 ago 2026
2800+
98%
2825+
93%
2850+
78%
$1,475 Vol.
2800+
$575 Vol.
98%
2825+
$346 Vol.
93%
2850+
$553 Vol.
78%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Ongoing measles transmission across multiple U.S. outbreaks continues to drive case counts sharply higher, with the CDC confirming 2,777 cases through August 20, 2026—already exceeding the full-year 2025 total of 2,289. Roughly 94% of 2026 infections link to 36 active outbreaks, concentrated in communities with lower MMR vaccination coverage that enable sustained chains of the highly contagious virus. Weekly CDC surveillance updates have added 100–211 cases recently, reflecting both local spread and travel-related introductions. With the August 31 resolution date approaching, the next CDC report expected late this week will provide the final confirmed tally before market close, highlighting how vaccination gaps and outbreak persistence shape the trajectory of this year’s record resurgence.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Mercato aperto: Aug 24, 2026, 10:08 AM ET
Volume
$1,475Data di fine
31 ago 2026Mercato aperto
Aug 24, 2026, 10:08 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Ongoing measles transmission across multiple U.S. outbreaks continues to drive case counts sharply higher, with the CDC confirming 2,777 cases through August 20, 2026—already exceeding the full-year 2025 total of 2,289. Roughly 94% of 2026 infections link to 36 active outbreaks, concentrated in communities with lower MMR vaccination coverage that enable sustained chains of the highly contagious virus. Weekly CDC surveillance updates have added 100–211 cases recently, reflecting both local spread and travel-related introductions. With the August 31 resolution date approaching, the next CDC report expected late this week will provide the final confirmed tally before market close, highlighting how vaccination gaps and outbreak persistence shape the trajectory of this year’s record resurgence.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$1,475Data di fine
31 ago 2026Mercato aperto
Aug 24, 2026, 10:08 AM ETResolver
0x65070BE91...Ongoing measles transmission across multiple U.S. outbreaks continues to drive case counts sharply higher, with the CDC confirming 2,777 cases through August 20, 2026—already exceeding the full-year 2025 total of 2,289. Roughly 94% of 2026 infections link to 36 active outbreaks, concentrated in communities with lower MMR vaccination coverage that enable sustained chains of the highly contagious virus. Weekly CDC surveillance updates have added 100–211 cases recently, reflecting both local spread and travel-related introductions. With the August 31 resolution date approaching, the next CDC report expected late this week will provide the final confirmed tally before market close, highlighting how vaccination gaps and outbreak persistence shape the trajectory of this year’s record resurgence.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · Aggiornato
Fai attenzione ai link esterni.
Fai attenzione ai link esterni.
Domande frequenti